 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/20/2017 |
$72.99 |
$74.22 |
$72.94 |
$74.01 |
5.33M | | 07/21/2017 |
$73.98 |
$75.04 |
$73.85 |
$74.63 |
4.96M | | 07/24/2017 |
$74.63 |
$74.75 |
$73.84 |
$73.91 |
5.50M | | 07/25/2017 |
$74.40 |
$74.55 |
$72.47 |
$72.52 |
6.35M | | 07/26/2017 |
$72.37 |
$72.69 |
$71.95 |
$72.59 |
4.68M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on July 20, 2017, ABBV opened at $72.99, traded as high as $74.22 and as low as $72.94, and closed at $74.01. Trading volume was a total of 5.33M shares. On July 21, 2017, ABBV opened at $73.98, traded as high as $75.04 and as low as $73.85, and closed at $74.63. Trading volume was a total of 4.96M shares. On July 24, 2017, ABBV opened at $74.63, traded as high as $74.75 and as low as $73.84, and closed at $73.91. Trading volume was a total of 5.50M shares. On July 25, 2017, ABBV opened at $74.40, traded as high as $74.55 and as low as $72.47, and closed at $72.52. Trading volume was a total of 6.35M shares. On July 26, 2017, ABBV opened at $72.37, traded as high as $72.69 and as low as $71.95, and closed at $72.59. Trading volume was a total of 4.68M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
07/26/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$72.59 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
338.06 |
|
| Dividends reinvested/share: |
$9.48 |
|
| Total return: |
145.40% |
|
| Average Annual Total Return: |
21.75% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$24,540.25 |
|
| Years: |
4.56 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
07/26/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$72.59 |
|
| Dividends collected/share: |
$9.48 |
|
| Total return: |
133.68% |
|
| Average Annual Total Return: |
20.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,367.48 |
|
| Years: |
4.56 |
|
|
|
| Date |
Close |
| 07/20/2017 | $74.01 | | 07/21/2017 | $74.63 | | 07/24/2017 | $73.91 | | 07/25/2017 | $72.52 | | 07/26/2017 | $72.59 |
|
|
